1. Home
  2. GKOS vs INSP Comparison

GKOS vs INSP Comparison

Compare GKOS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • INSP
  • Stock Information
  • Founded
  • GKOS 1998
  • INSP 2007
  • Country
  • GKOS United States
  • INSP United States
  • Employees
  • GKOS 995
  • INSP N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • INSP Medical/Dental Instruments
  • Sector
  • GKOS Health Care
  • INSP Health Care
  • Exchange
  • GKOS Nasdaq
  • INSP Nasdaq
  • Market Cap
  • GKOS 5.1B
  • INSP 4.4B
  • IPO Year
  • GKOS 2015
  • INSP 2018
  • Fundamental
  • Price
  • GKOS $90.26
  • INSP $150.21
  • Analyst Decision
  • GKOS Strong Buy
  • INSP Buy
  • Analyst Count
  • GKOS 13
  • INSP 10
  • Target Price
  • GKOS $155.00
  • INSP $222.20
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • INSP 473.9K
  • Earning Date
  • GKOS 04-30-2025
  • INSP 05-05-2025
  • Dividend Yield
  • GKOS N/A
  • INSP N/A
  • EPS Growth
  • GKOS N/A
  • INSP N/A
  • EPS
  • GKOS N/A
  • INSP 1.75
  • Revenue
  • GKOS $383,481,000.00
  • INSP $802,804,000.00
  • Revenue This Year
  • GKOS $27.84
  • INSP $20.65
  • Revenue Next Year
  • GKOS $27.99
  • INSP $17.49
  • P/E Ratio
  • GKOS N/A
  • INSP $85.83
  • Revenue Growth
  • GKOS 21.85
  • INSP 28.49
  • 52 Week Low
  • GKOS $77.91
  • INSP $123.00
  • 52 Week High
  • GKOS $163.71
  • INSP $257.40
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 41.57
  • INSP 44.54
  • Support Level
  • GKOS $86.16
  • INSP $137.97
  • Resistance Level
  • GKOS $94.55
  • INSP $152.25
  • Average True Range (ATR)
  • GKOS 6.54
  • INSP 10.34
  • MACD
  • GKOS 1.11
  • INSP 0.57
  • Stochastic Oscillator
  • GKOS 54.51
  • INSP 55.92

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: